Cargando…
Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness
Critical illnesses including sepsis, acute respiratory distress syndromes, ischemic cardiovascular disorders and acute organ injuries are associated with high mortality, morbidity as well as significant health care system expenses. While these diverse conditions require different specific therapeuti...
Autores principales: | Varkouhi, Amir K., Monteiro, Ana Paula Teixeira, Tsoporis, James N., Mei, Shirley H. J., Stewart, Duncan J., dos Santos, Claudia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363458/ https://www.ncbi.nlm.nih.gov/pubmed/32671645 http://dx.doi.org/10.1007/s12015-020-10000-1 |
Ejemplares similares
-
Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis
por: Ektesabi, Amin M., et al.
Publicado: (2021) -
Protective function of DJ-1/PARK7 in lipopolysaccharide and ventilator-induced acute lung injury
por: Amatullah, Hajera, et al.
Publicado: (2020) -
Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a-5p in recipient mice
por: Younes, Nadim, et al.
Publicado: (2020) -
Validation of reference gene stability for miRNA quantification by reverse transcription quantitative PCR in the peripheral blood of patients with COVID-19 critical illness
por: Formosa, Amanda, et al.
Publicado: (2023) -
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
por: Thompson, Mary, et al.
Publicado: (2020)